Bayer CropScience completes acquisition of biotech company Athenix Corp.
Purchase price of USD 365 million plus milestones. - - Monheim.– Bayer CropScience announced today the completion of its purchase of Athenix Corp., a privately-held independent biotechnology company he... [read full story]
|
RELATED
|
|
Boston Millennia benefits from sale of biotech firm
Boston Millennia Partners , a private equity firm, said that one of its portfolio companies, Athenix Corp., has been acquired by Bayer CropScience for $400 million. According to Boston Millennia Partners, the sale generated a...
Local VCs cash out in $400M Athenix deal (at bizjournals.com)
The two Boston-area venture firms invested in all of North Carolina-based Athenix’s three funding rounds, backing the biotechnology company to the tune of some $33 million. Co-investors included Eastman Ventures, the venture...
Boston Millennia Partners Announces the Sale of its Portfolio Company Athenix to Bayer...
Boston Millennia Partners is pleased to announce that its portfolio company, Athenix Corporation, has been acquired by Bayer CropScience for $400 million. This is the second BMP II portfolio company sold for a 10X return.
Boston Millennia Partners Announces the Sale of its Portfolio Company Athenix to Bayer...
BOSTON, Nov. 4 /PRNewswire/ -- Boston Millennia Partners (BMP II) is pleased to announce that its portfolio company, Athenix Corporation, has been acquired by Bayer CropScience for $400 million. This is the second BMP II...
Boston Millennia Partners Announces the Sale of its Portfolio Company Athenix to Bayer...
BOSTON, Nov. 4 /PRNewswire/ -- Boston Millennia Partners (BMP II) is pleased to announce that its portfolio company, Athenix Corporation, has been acquired by Bayer CropScience for $400 million. This is the second BMP II...
Athenix price tag: $365 million
Bayer CropScience today announced the completion of its previously announced acquisition of Athenix, a Research Triangle Park biotechnology company, and also disclosed the puchase price: $365 million. Bayer CropScience also...
02.11.09: Successful purchase of trait platform with extensive product pipeline:
Bayer CropScience completes acquisition of biotech company Athenix Corp. Purchase price of USD 365 million plus milestones Monheim, November 2, 2009 - Bayer CropScience announced today the completion of its purchase of Athenix...
International Editions
English - US | English - UK | Deutsch | Français | Español - España | Português - Portugal | Italiano | Čeština | Русский (Russian) | عربي (Arabic) | 中文（简）(Simplified Chinese) | Español - México | Português - Brasil | 한국어 (Korean) | English - India
